Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-16-093158

Director sold 300,000 shares at $2.35 ($705,000)

From the SEC's structured data for this filing

Trades in this filing

KINGSLEY ALFRED D · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-01-20 Sale : show line 1 in the form −300,000 $2.35 $705,000 5,638,055 D
Open-market sales · 300,000 sh · avg $2.35 · $705,000
Loading xslF345X03/doc4.xml…